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ABSTRACT 
 
Pro-inflammatory cytokine release (IL-8, IL-6, TNFIL-1) by peripheral blood 
neutrophils (PBN), isolated from periodontitis patients (before/after therapy) and matched 
controls, was determined after 18h culture in the presence/absence of Escherichia coli 
LPS, opsonised Staphylococcus aureus, heat-killed Fusobacterium nucleatum and 
Porphyromonas gingivalis.  All cultures demonstrated differences in the amounts of each 
cytokine detected (P<0.0001), with a clear release pattern (IL-8>IL-6>TNFα=IL-1β). 
Median cytokine release from unstimulated patient neutrophils was consistently, but non-
significantly, higher than from control cells. Stimulated cytokine release from untreated 
patient neutrophils was also consistently higher than control cells.  This hyper-reactivity 
was significant for all tested cytokines when data for all stimuli were combined 
(P<0.016).  In terms of individual stimuli, significant hyper-reactivity was detected with 
LPS (IL-8; P<0.04), F. nucleatum (IL-8, TNF; P<0.05), opsonised S. aureus (IL-8, 
TNF, IL-1; P<0.05) and P. gingivalis (IL-8, IL-1; P<0.032). Cytokine production by 
patient neutrophils did not reduce following successful non-surgical periodontal therapy 
and, except for responses to F. nucleatum, the cytokine hyper-reactivity detected pre-
therapy was retained. These data demonstrate that chronic periodontitis is characterised 
by neutrophils that constitutively exhibit cytokine hyper-reactivity, the effects of which 
could modulate local and systemic inflammatory-immune responses and influence the 
risk and severity of periodontitis-associated systemic inflammatory diseases.  
 
Key words: Cytokine; interleukin; neutrophil; periodontitis; TNFα. 
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INTRODUCTION 
 
Chronic periodontitis is one of the most prevalent chronic inflammatory diseases of 
humans and in its most severe form is the sixth most prevalent disease of man, affecting 
11.2% of the global population and representing a substantial public health burden.1 The 
pathogenesis of chronic periodontitis is associated with a dysregulated host 
inflammatory-immune response to intra-oral plaque bacteria,2 which is responsible for 
the majority of periodontal tissue damage.3 A hyper-inflammatory neutrophil phenotype 
is considered central to the pathogenesis of chronic periodontitis4 and also many of the 
systemic inflammatory diseases associated with periodontitis including type-2 diabetes5 
and cardiovascular disease.6 As such, neutrophilic “hyper-inflammation” may represent 
one causal mechanism by which periodontitis contributes to co-morbidity. 
Coordination of inflammatory-immune responses including neutrophil function 
involves the release of locally-produced and systemically circulating cytokines.7 
Originally, monocytes and lymphocytes were regarded as the predominant source of pro-
inflammatory cytokines in inflammatory lesions with neutrophils thought to produce only 
IL-8.8 However, neutrophils themselves have been shown to release physiologically-
relevant concentrations of various cytokines including IL-8, IL-6, TNFα and IL-1β9-11 
and therefore play an active role in co-ordinating the inflammatory-immune response, in 
addition to their traditional antimicrobial activity.12 Given the large numbers of 
neutrophils in peripheral blood and that they represent the dominant inflammatory cell in 
the periodontal tissues during periodontitis, neutrophil cytokine release is likely to 
significantly impact on the host response locally and systemically, with the latter 
increasing the risk of co-morbidity. 
 There have been few studies of neutrophil-derived cytokines in the pathogenesis 
of periodontitis and related systemic disease, despite their potential importance. The 
majority of studies investigating cytokines in chronic periodontitis have been performed 
on plasma, GCF and tissue biopsy samples, and have generally shown higher levels in 
disease. To date, there have been only three published studies investigating peripheral 
blood neutrophil cytokine release in patients with chronic periodontitis.13-15 Two studies 
demonstrated no significant difference in neutrophil IL-8, IL-1β and TNF-α release in 
chronic periodontitis compared to healthy controls in the absence or presence of GM-CSF 
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or opsonised S. aureus.13, 14 By contrast, the third study reported significantly reduced 
neutrophil IL-8 release from patient neutrophils compared to control cells in the presence 
and absence of LPS, phytohemagglutin (PHA), zymosan A, P. gingivalis or A. 
actinomycetemcomitans.15 All these studies used short culture times to determine 
cytokine production (<5 hr), which may have been too short to accurately determine 
neutrophil cytokine production. Although the specific mechanisms involved in neutrophil 
cytokine release are incompletely defined,16 neutrophils are not known to store cytokines 
and time would be required for their synthesis and activation of pro-cytokine molecules 
following stimulation and prior to release.17 
Type-2 diabetes displays a unique bi-directional relationship with chronic 
periodontitis, namely that chronic periodontitis is a risk factor for type-2 diabetes and 
vice-versa,18 with periodontal treatment reliably shown to improve glycaemic control.19 
Peripheral blood neutrophils isolated from diabetes patients have recently been shown to 
release greater amounts of IL-8, IL-1β and TNFα when cultured for 18 hr, in the presence 
and absence of LPS, than neutrophils isolated from healthy controls.5 To date, there are 
no studies investigating cytokine release, in the presence or absence of recognised 
periodontal pathogens, within an extended (18 hr) culture period, from neutrophils 
isolated from patients with chronic periodontitis.  Furthermore, there have been no studies 
on the effects of successful periodontal therapy on neutrophil cytokine production in 
periodontitis. 
Here we determined neutrophil cytokine release following 18 hr culture in the 
absence of and following stimulation with E. coli LPS, opsonised S. aureus and the 
periodontal pathogens, F. nucleatum and P. gingivalis. In addition, the effect of non-
surgical periodontal therapy and stabilisation of periodontal disease on neutrophil 
cytokine release was also investigated. Given the increasing awareness of the ability of 
neutrophils to secrete cytokines and co-ordinate the inflammatory-immune response, we 
hypothesised that increased cytokine release from peripheral blood neutrophils may be 
involved in the pathogenesis of chronic periodontitis and have a potential role in 
associated systemic diseases. 
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MATERIALS & METHODS 
 
Ethical approval 
Ethical approval was granted by the West Midlands Research Ethics Committee (REC 
reference no. 10/H1208/48). National Health Service (NHS) permission was granted by 
the Birmingham Community Healthcare NHS Trust on behalf of the Birmingham and the 
Black Country Comprehensive Local Research Network (BBC CLRN) Research 
Management & Governance (RM&G) Consortium Office (NHS R&D reference no. 
R&D1398; RM&G reference no. BCHCTDent265.1398.P). The study was adopted onto 
the National Institute of Health Research Network Portfolio (NIHR UKCRN Study ID 
10318). The study was also registered on ClinicalTrials.gov (Identifier NCT01233765). 
The study was classified as a clinical study and came under the Department of Health 
Research Governance Framework for Health and Social Care. 
 
Volunteer recruitment 
Volunteers diagnosed with chronic periodontitis (n=20) were recruited from patients 
referred to the Birmingham Dental Hospital for clinical evaluation and treatment (12 male 
and 8 female; mean age = 46+8 yrs, range 37-61 yr). Chronic periodontitis was defined 
as the presence of at least two non-adjacent sites with probing pocket depths >4mm, along 
with radiographic bone loss >30% of the root length (non-first molar or incisor sites) in 
accordance with the consensus criteria of the European Federation of Periodontology.20 
Age- and gender-matched periodontally healthy control volunteers (n=20) were recruited 
from Staff of the Birmingham Dental Hospital & School (12 male, 8 female; mean age = 
46+8 yrs, range 32-62 yr). There were no significant differences in patient and control 
volunteer age as determined by Mann-Whitney test. Control volunteers had no evidence 
of attachment loss, no probing pocket depths >4mm and whole-mouth bleeding scores 
<10%. All volunteers were never-smokers and systemically healthy as confirmed by a 
detailed medical history questionnaire.  
 
Periodontal assessment 
Clinical measures included probing pocket depth and recession using a PCP-UNC-15 
periodontal probe (Hu-Friedy Manufacturing Co., Chicago, IL). Bleeding on probing was 
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recorded in conjunction with the probing pocket depth measurements. Gingival 
inflammation was measured using the Löe gingival index.21 The presence of dental plaque 
was measured using the modified Quigley & Hein plaque index.22 All clinical measures 
were recorded on 6 sites per tooth (3 measurements on each of the buccal/labial and 
palatal/lingual thirds) by a single calibrated examiner at baseline and 2 months post-
therapy. 
 
Non-surgical periodontal therapy 
Patient volunteers received tailored oral hygiene instruction and conventional non-
surgical periodontal therapy by a single operator. This consisted of scaling and root 
surface debridement (RSD) of all periodontal pockets >4 mm performed under local 
anaesthesia on a quadrant-by-quadrant basis within a maximum of 4 weeks.  
 
Neutrophil isolation 
Peripheral blood was obtained from volunteers with chronic periodontitis and age-
/gender-matched controls before (baseline; n=20) and following conventional non-
surgical periodontal therapy (review; n=19). Blood was obtained between 09:00 and 
10:00 am from a patient and a matched healthy control volunteer within 30 minutes of 
each other. Blood was collected from the antecubital fossa into Vacutainers (Greiner, Bio-
One Ltd, Stonehouse, UK) containing lithium heparin (17 IU/ml) as anticoagulant. 
Neutrophils were isolated using a discontinuous Percoll gradient (δ = 1.079:1.098), 
followed by erythrocyte lysis (0.83 % NH4Cl containing 1 % KHCO3, 0.04 % 
Na2EDTA.2H2O and 0.25 % bovine serum albumin; 20 min). Isolated cells were >99 % 
polymorphonuclear cells morphologically and devoid of erythrocytes and monocytes. 
The absence of monocytes in cells prepared using this method has been confirmed 
previously within our laboratory by gene expression analyses.23 Giemsa stained cell 
smears24 also confirmed the presence of >99 % neutrophils in the cell preparation. 
Neutrophil isolation was performed at room temperature within a Biological Safety 
cabinet (Jouan Microbiological Safety Cabinet BS 5726) using aseptic technique.  
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Preparation of bacterial stimuli 
Fusobacterium nucleatum (Fn; ATCC 10953) and Porphyromonas gingivalis (Pg; ATCC 
33277) were grown anaerobically at 37oC as previously described.25 Staphylococcus 
aureus (NCTC 6571) was grown in air on mannitol salt agar and inoculated into tryptone 
soya broth. Bacteria were washed 3 times in sterile PBS and heat-treated (100 oC for 10 
min) prior to dilution with sterile PBS to give a final suspension of 8.5 x 109 and 4.12 x 
109 for F. nucleatum and P. gingivalis respectively, and stored at -80oC. The number of 
F. nucleatum and P. gingivalis in cell suspensions was determined by measuring the 
optical density at 600nm using conversion factors previously determined by the Forsyth 
Institute, Boston, USA (OD1.0600nm = 1.62x10
9 for F. nucleatum and 1.69x109 for P. 
gingivalis).25 The bacterial density of S. aureus suspensions was determined by plate 
colony counting. Opsonised S. aureus was prepared as previously described 26 and stored 
as a 1.1 x 1011 cells/ml suspension at -80oC. Escherichia coli serotype O26:B6 
lipopolysaccharide (LPS; Sigma L5543) was supplied as a 1mg/ml, 0.2 µm filtered, 
aqueous solution as confirmed by the product information sheet.  
 
Neutrophil culture 
Freshly isolated neutrophils were immediately washed at room temperature in PBS prior 
to re-suspension in RPMI-1640 (Sigma R8758) supplemented with 0.3 g/l glutamine, 2.32 
g/l HEPES, 2g/l sodium bicarbonate, 100 µg/ml streptomycin, 100 IU/ml penicillin and 
10 % heat-inactivated fetal bovine serum. Neutrophils were cultured at 2.5 x 106 cells/ml 
(18 hr at 37oC and 5% CO2) in the presence of LPS (5µg/ml), F. nucleatum (MOI 100:1), 
P. gingivalis (MOI 100:1), opsonised S. aureus (MOI 300:1) or additional RPMI as 
negative control. Neutrophil viability was determined immediately before and after 18 hr 
culture by trypan blue dye exclusion.  
 
Determination of neutrophil cytokine release  
Following 18 hr culture, neutrophil cell culture supernatants were collected aseptically 
and stored at -80oC. Commercial enzyme-linked immunosorbent assay (ELISA) kits 
(R&D Systems, Abingdon, UK) were used to measure IL-8, IL-6, TNFα and IL-1β levels 
within the neutrophil culture supernatants. All samples were allowed to equilibrate to 
room temperature before use. Standards and samples were assayed in duplicate according 
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to the manufacturer’s instructions. All cytokine data were calculated to the nearest whole 
value in pg/ml due to the reported ELISA assay sensitivities and inter-assay variation 
(typically >1pg/ml) as specified within the product information sheets. 
 
Data handling and statistical analyses 
Data were recorded and manipulated in Microsoft Excel and evaluated using GraphPad 
Prism 5 (version 5.04; GraphPad Software, La Jolla, CA, USA). Data distribution was 
determined using the Kolmogorov-Smirnov test. Differences in probing pocket depths, 
the only dataset found to be normally distributed, were determined by ANOVA followed 
by Tukey-Kramer multiple comparisons test.  All other statistical comparisons were 
performed using non-parametric methods as indicated in the text and/or figures/tables. 
Except for probing pocket depths, all data were reported as median and interquartile 
range. In order to assist graphical representation of the cytokine data, “outliers” were 
determined (calculated as >1.5x interquartile range)27 and plotted outside the boxplot, 
with the most extreme values above the y-axis maximum. All cytokine concentrations, 
including outlying values, were included in all statistical analyses. 
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RESULTS 
 
Longitudinal changes in clinical measures 
The success of non-surgical periodontal therapy was confirmed by improvements in all 
clinical measures of the disease at the 2 month post treatment review (Table 1; P<0.05). 
At review, there were no significant differences between patient and control volunteers 
regarding the percentage of sites exhibiting bleeding on probing or the gingival and 
plaque indices. However, patient volunteers continued to demonstrate greater mean 
probing pocket depths and number of sites >4 mm (P<0.01), despite significantly 
reducing from their baseline pre-treatment values (P<0.05).  
 
Neutrophil viability following culture 
There were no significant differences in neutrophil viability following 18 hr culture 
between patient (mean 97.7 + 2.3%; range 94.1–100%) and control cells (mean 97.5 + 
1.8%; range 93.5–100%; data not shown). However, neutrophil viability in the presence 
of opsonised S. aureus (mean 95.4 + 2.8%; range 90.9–100%) was significantly lower 
than in cultures containing additional RPMI or other stimuli (mean 98.9 + 0.4%; range 
98.4–99.2%; P<0.05; Friedman/Dunn’s test). 
 
Unstimulated neutrophil cytokine release 
Cytokine release from essentially unstimulated neutrophils cultured in the presence of 
additional RPMI (vehicle control) is shown in Table 2. At both baseline and review there 
were significant differences in the amounts of each cytokine detected in the 18 hr culture 
supernatants irrespective of whether they were patient or control cells (P<0.0001; 
Friedman test), with a clear pattern of release (IL-8>IL-6>TNFα=IL-1β).  However there 
was considerable individual variation in cytokine release as evidenced by the interquartile 
ranges in relation to the median. Overall, the levels of all cytokines released from patient 
neutrophils were higher than those from controls. This difference was not significant 
when comparing data for all cytokines combined (i.e. total cytokine production) or 
individual cytokines, except at review, when patient cells released higher amounts of IL-
6 than control neutrophils (P=0.033; Table 2).  However, this latter difference coincided 
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with a significant decrease in detectable IL-6 release from control cells at review 
(P=0.03). 
 
Stimulated neutrophil cytokine release 
Neutrophils demonstrated a positive cytokine response to all stimuli employed (IL-8, 
TNF & IL-1, P<0.0004; IL-6, P<0.0012; Figures 1-4).  
Initially, the IL-8, IL-6, TNFα and IL-1β data for all stimuli combined were 
analysed to reflect the multiple host and plaque-associated factors capable of stimulating 
neutrophils. Combined stimulated cytokine levels from patient cells were consistently 
higher than from control cells both at baseline and review (P<0.016; Table 3) with no 
significant differences between baseline and review visits for control or patient cells with 
the exception of a significant increase in TNFα release by patient cells at review 
(P=0.007; Table 4). In agreement with unstimulated cytokine release, there were 
significant differences in the amounts of each cytokine detected in the 18 hr culture 
supernatants of patient and control cells following stimulation (P<0.0001 for baseline and 
review; Kruskal-Wallis test) with a similar pattern of release (IL-8>IL-6>TNFα=IL-1β).  
At both baseline and review the median levels of all 4 cytokines released were 
highest from patient cells irrespective of which stimulus was used (Figures 1-4).  When 
analysing the data for individual stimuli, several therapy-/stimulus-related differences 
between cytokine release from patient and control cells were detected (Figures 1-4 & 
summarised in Table 4).  Patient neutrophils released greater amounts of IL-8 and TNFα 
than controls in the presence of the periodontopathogen F. nucleatum at baseline 
(P<0.05), with no significant differences at post-treatment review.  However, this 
apparent therapy-related change was not reflected by a significant reduction in cytokine 
production by patient cells post-therapy. By contrast, heightened FcγR-stimulated 
neutrophil IL-8, TNF-α and IL-1 release was a consistent feature of periodontitis 
neutrophils at both baseline (P<0.05) and review (P<0.023).  Furthermore, greater release 
of IL-8 and IL-1 by patient cells was also a consistent feature after stimulation with P. 
gingivalis (baseline, P<0.032; review, P<0.036), as was production of IL-8 in response 
to E. coli LPS (baseline, P=0.038; review, P=0.015). 
Release of IL-8, IL-6 and IL-1 by patient cells was unaffected by therapy.  
However, TNF release by patient cells in response to opsonised S. aureus (P=0.015) 
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and P. gingivalis (P=0.035) was significantly higher at the post therapy review, as was 
TNF production when combining the data for all stimuli (P=0.007; Table 4).  
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DISCUSSION 
 
The data from this study demonstrate, for the first time, that peripheral blood neutrophils 
from patients with chronic periodontitis release greater amounts of cytokines (IL-8, IL-6, 
TNFα and IL-1β) compared to those from healthy individuals and exhibit a hyper-reactive 
phenotype in terms of cytokine production in response to a variety of stimuli, including 
the periodontitis-associated periodontal bacteria, P. gingivalis and F. nucleatum.  
Furthermore, this is the first longitudinal intervention study analysing the impact of 
therapeutic reductions in periodontal inflammation on the ability of peripheral blood 
neutrophils to generate cytokines in the presence and absence of periodontally relevant 
stimuli. In most instances, the observed cytokine hyper-reactivity of patient neutrophils 
and their ability to release cytokines was not altered by successful non-surgical therapy.  
Together, these novel data are consistent with current literature highlighting a 
dysregulated neutrophil phenotype in chronic periodontitis pathogenesis and are 
significant because cytokines regulate many different aspects of the inflammatory-
immune response known to be altered in periodontitis28 including neutrophil reactive 
oxygen species (ROS) generation,29, 30 extracellular trap (NET) release31 and directional 
chemotactic accuracy.32  
Although median levels of unstimulated cytokine release were highest for patient 
cells, the difference, compared to control cell levels, was not significant for either the 
combined or individual cytokine data, except for IL-6 at review. This latter result was due 
to a significant decrease in control neutrophil IL-6 release at review compared to baseline, 
despite no known intervention between the sampling visits.  Thus, our 18 hour culture 
data do not provide evidence that unstimulated peripheral blood neutrophils from 
periodontitis patients are hyperactive in terms of baseline, unstimulated cytokine release 
and agree with two reports using shorter (1-5h) culture times.13, 14 By contrast, the 
reported 4-6 times lower unstimulated release of IL-8 from patient cells compared to 
control neutrophils, where none of the cells responded to stimuli including E. coli LPS 
and zymosan A15, is not supported. However, further studies on larger numbers are 
required to determine whether the generally higher median release of cytokines by patient 
cells reported here would become statistically significant.  This is of potential importance 
because even small differences in “baseline”, unstimulated cytokine release may be 
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biologically important in the pathogenesis of periodontitis, given the large numbers of 
systemic and locally recruited neutrophils within the periodontium and the chronic nature 
of the disease.   
Although cytokine hyperactivity (increased cytokine release in the absence of 
stimulation) was not statistically significant, greater stimulated IL-8, IL-6, TNFα and IL-
1β release from patient compared to control neutrophils was a consistent feature when 
comparing data for all stimuli combined demonstrating that patient cells are hyper-
reactive in terms of cytokine production. While these analyses of cytokine responses to 
multiple stimuli suggest that patient neutrophils will be hyper-reactive to the many host 
and plaque-associated factors known to be simultaneously present within periodontal 
tissues and blood,33 it is important to remember that our data are based on summation of 
cytokine release stimulated by individual stimuli rather than responses to the combined 
stimuli. 
The pattern of stimulated cytokine responses by neutrophils from patient cells 
varied according to the individual stimulus and cytokine investigated. Untreated patient 
neutrophils released significantly greater amounts of IL-8 in response to all tested stimuli 
compared to control cells.  By contrast, there were no significant differences in stimulated 
IL-6 release between patient and control cells for any of the stimuli.  TNFα and IL-1β 
release by patient cells showed an intermediate response profile showing hyper-reactivity 
to opsonised S. aureus (TNFα & IL-1β), F. nucleatum (TNF) and P. gingivalis (IL-1).     
The FcγR-stimulated IL-8, TNFα and IL-1β hyper-reactivity presented in this 
study contrasts with the lack of significant differences between periodontitis and control 
neutrophils previously reported (Fredriksson et al. 2002). However, Fredriksson et al. 
utilised a 5 hr culture time and detected only low levels of FcγR-stimulated IL-8 (range 
16-64 pg/ml) and TNFα (range 13-248 pg/ml).  By comparison, high levels of cytokine 
were detected in this study (stimulated ranges: IL-8, 496-118466 pg/ml; TNFα, 2-8326 
pg/ml) using an 18 hr culture period, a time known to correspond to that required for the 
majority of stimulated neutrophil IL-8, IL-6, TNFα and IL-1β to be released (16-18 hr).34, 
35  Similarly, the significantly greater E. coli LPS and P. gingivalis-stimulated IL-8 
release from patient compared to control neutrophils presented here contrasts with a study 
reporting lower E. coli LPS and P. gingivalis-stimulated IL-8 release from periodontitis 
neutrophils.15 However, this latter study only used a 1 hr culture time and failed to 
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demonstrate stimulation of control neutrophils, which produced extremely high levels of 
IL-8 (~800ng) in the absence of stimulation.  
This is the first known study to investigate the effect of successful periodontal 
treatment on peripheral blood neutrophil cytokine release. There were no detectable 
changes in IL-8, IL-6 or IL-1β production by patient neutrophils at the post-therapy 
review, indicating that any neutrophil cytokine hyperactivity/-reactivity detected was 
constitutive rather than being secondary to the inflammatory process. Indeed, significant 
differences between patient and control cell release of IL-8, IL-6 and IL-1 detected pre-
therapy were also demonstrated post-therapy, except for F. nucleatum-stimulated IL-8.  
This finding contrasts with data on FcγR-stimulated neutrophil ROS hyper-reactivity in 
periodontitis, which is not detectable following treatment.30  In contrast to IL-8, IL-6 or 
IL-1β, a therapy-related increase in TNF release by patient cells was detected when 
analysing responses to opsonised S. aureus, P. gingivalis and all stimuli combined. 
Although this change had no positive effect on TNF hyper-reactivity detected at pre-
therapy baseline, it is difficult to explain why reducing the inflammatory burden to the 
body, by reducing the periodontal bacterial load and inflammation, should apparently 
increase stimulated TNFα production by patient neutrophils. 
In terms of periodontitis, an important and novel finding was the consistent IL-8 
and IL-1 hyper-reactivity of patient cells to P. gingivalis, a bacterium strongly 
associated with chronic periodontitis.36   Porphyromonas gingivalis LPS is structurally 
distinct from other sources of LPS,37 induces cytokine production via different signalling 
mechanisms38 and is heterogenous, with some P. gingivalis LPS molecules binding to 
TLR-2, others to TLR-4 and, possibly, also to receptor antagonists.39, 40 Taken together, 
a constitutive defect in TLR receptor or downstream signalling relating to IL-8 and IL-1β 
release may explain the persistent hyper-reactive P. gingivalis-stimulated cytokine 
release from patient compared to control neutrophils detected in this study. 
In contrast to the response to P. gingivalis, neutrophil hyper-reactivity to F. 
nucleatum, a bacterium known to be important in plaque associated with periodontitis,36, 
41 was detected before treatment (IL-8 & TNF) but could not be demonstrated post-
therapy.  As patient levels of both cytokines were not lowered after treatment, this 
apparent loss of hyper-reactivity cannot be attributed to reduced periodontal bacterial load 
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and inflammation. Further studies are obviously required to determine the significance of 
these observations.      
Dysregulated neutrophil cytokine release, namely cytokine hyper-reactivity to 
periodontal pathogens and FcγR activation, could have a number of different 
consequences on the inflammatory-immune response in relation to the pathogenesis of 
chronic periodontitis. Greater neutrophil IL-8, IL-6, and TNFα release may result in 
neutrophil priming for greater ROS release.42, 43 Increased extracellular ROS release may 
then result in collateral host tissue damage as a result of osteoclast activation causing 
bone resorption44 in addition to degradation of type I collagen of the periodontal 
ligament.45 Neutrophil ROS and IL-8 release will also result in NET formation46, 47 which, 
if excessive, may result in the generation of autoantibodies48 along with impairing the 
inflammatory-immune response by sequestering local cytokine dissemination.49 
Heightened release of IL-8, IL-6, TNFα and IL-1β by neutrophils could also trigger 
neutrophil antimicrobial enzyme and granule protein release with the potential to cause 
destruction of adjacent periodontal connective tissue.50 
In addition to the above, there are a variety of indirect effects of dysregulated 
neutrophil cytokine release that could impact on the pathogenesis of chronic periodontitis. 
For example, neutrophil IL-8 release is likely to affect concurrent neutrophil chemotaxis 
and recruitment within the periodontal tissues.51 Our group have demonstrated that 
peripheral blood neutrophils from periodontitis patients display impaired directional 
chemotactic accuracy32 and, in this patient and control cohort, we have shown a moderate 
positive correlation between neutrophil IL-8 release and chemotactic index towards 
fMLP, suggesting that neutrophil IL-8 release may assist with neutrophil chemotaxis 
towards bacterial-derived chemo-attractants (Ling MR, Chapple IL, Roberts HM., 
Matthews JB, unpublished observations). In addition, any adaptive immune response will 
be heightened by IL-8, IL-6 and TNFα resulting in T-cell activation which is also directly 
influenced by IL-6.52 The generation of antibodies and bacterial opsonisation will result 
in FcγR-stimulated neutrophil activation thereby further exacerbating the inflammatory-
immune response in relation to the persistent FcγR-stimulated IL-8, IL-6, IL-1β and 
TNFα release and FcγR-stimulated neutrophil ROS hyper-reactivity in chronic 
periodontitis.30 
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Overall, the data presented in this study demonstrate that neutrophils from 
untreated periodontitis patients are hyper-reactive to a variety of disease-associated 
stimuli with regards to IL-8, IL-6, TNFα and IL-1β release compared to cells from healthy 
control individuals.  Furthermore, production of cytokines by patient cells was not 
reduced after successful non-surgical periodontal therapy and, except for responses to F. 
nucleatum, cytokine hyper-reactivity detected pre-therapy was shown to be retained.  
These data suggest that neutrophil cytokine hyper-reactivity is not secondary to the 
inflammatory reaction within the periodontal tissues during periodontal disease but is the 
result of constitutive differences in neutrophils isolated from controls and periodontitis 
patients.  Such a difference in neutrophil reactivity could modulate both local and 
systemic inflammatory-immune responses and influence the risk and severity of 
periodontitis, as well as periodontitis-associated systemic inflammatory disease. 
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TABLE LEGENDS 
 
Table 1. 
Clinical measures of chronic periodontitis patients before (baseline; n=20) and 2 months 
after (review; n=19) non-surgical periodontal therapy and matched healthy controls 
(n=20).   One patient (no. 13) elected to discontinue participation in the study during the 
treatment phase of the study. Probing pocket depths [mean+SD] were compared by one-
way ANOVA followed by Tukey-Kramer multiple comparisons test. All other 
comparisons [median (IQ range)] were performed using Kruskal-Wallis test followed by 
Dunn’s multiple comparisons test.  
* comparison with controls   # comparison with chronic periodontitis before treatment 
 
Table 2. 
Unstimulated IL-8, IL-6, TNFα and IL-1β release (pg/ml) from patient (n=19) and control 
(n=19) neutrophils at baseline and review. Data presented as median (interquartile range) 
pg/ml.  For both patient and control cells at baseline and review, levels of IL-8 were 
higher than IL-6 (P<0.05), which were higher than TNFα and IL-1β (P<0.05).  There 
were no differences in levels of TNFα and IL-1β released (Dunn’s Test). * The only 
significant difference in unstimulated cytokine levels between patient & control cells was 
for IL-6 at review (P=0.033; Bonferroni corrected, 1-tailed Mann-Whitney). 
 
Table 3. 
Stimulated IL-8, IL-6, TNFα and IL-1β release (pg/ml) from patient (n=19) and control 
(n=19) neutrophils at baseline and review in the presence of E. coli LPS (5µg/ml), F. 
nucleatum (MOI 100:1), IgG-opsonised S. aureus (MOI 300:1) and P. gingivalis (MOI 
100:1). Individual cytokine data presented as median (interquartile range) pg/ml for all 
stimuli combined (baseline, n=75; review, n=76). For both patient and control cells at 
baseline and review, levels of IL-8 were higher than IL-6 (P<0.001), which were higher 
than TNFα and IL-1β (P<0.001).  There were no differences in levels of TNFα and IL-1β 
released (Dunn’s Test). # Bonferroni corrected, 1-tailed Mann-Whitney test. * P=0.007, 
Bonferroni corrected, 2-tailed Wilcoxon test. 
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Table 4. 
Differences in cytokine release between patient and control neutrophils at baseline and 
review in response to individual (n=19; n=18 for opsonised S. aureus at baseline) and 
combined stimuli (n=75 at baseline and n=76 at review) (↑, patient>control; ↔, patient = 
control; Bonferroni corrected, 1-tailed Mann-Whitney) and change in cytokine release 
post-therapy (↑, increase; , decrease; ↔, no change at review; Bonferroni corrected 2-
tailed Wilcoxon).  
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Clinical measure 
Chronic periodontitis patients Controls 
(n=20) Baseline (n=20) Review (n=19) 
Probing pocket depth 
(mm; mean + SD) 
3.0+0.8 
(P<0.001)* 
2.1+0.5 
(P<0.001)# 
1.5+0.4 
Number of probing pocket depths >4 mm 
(median; range) 
27 (5-91) 
(P<0.001)* 
7 (0-52) 
(P<0.05)# 
0 (0-4) 
Percentage of sites bleeding on probing 
(median; range) 
43 (16-87) 
(P<0.001)* 
14 (3-35) 
(P<0.001)# 
2 (0-39) 
Gingival index 
(median; range) 
2 (1-3) 
(P<0.001)* 
1 (0-1) 
(P<0.001)# 
1 (0-1) 
Plaque index 
(median; range) 
2 (1-3) 
(P<0.001)* 
1 (0-2) 
(P<0.001)# 
1 (0-2) 
 
Table 1. Clinical measures of chronic periodontitis patients before (baseline; n=20) and 2 months after (review; n=19) non-surgical 
periodontal therapy and matched healthy controls (n=20).   One patient (no. 13) elected to discontinue participation in the study during 
the treatment phase of the study. Probing pocket depths [mean+SD] were compared by one-way ANOVA followed by Tukey-Kramer 
multiple comparisons test. All other comparisons [median (IQ range)] were performed using Kruskal-Wallis test followed by Dunn’s multiple 
comparisons test.  
 
* comparison with controls   # comparison with chronic periodontitis before treatment 
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Cytokine 
Patient Control 
Baseline Review Baseline Review 
IL-8 
479 
(267-1073) 
518 
(295-1,988) 
300 
(117-642) 
260 
(177-1,288) 
IL-6 
82 
(37-107) 
36* 
(18-107) 
45 
(23-141) 
16* 
(11-53) 
TNFα 
8 
(4-12) 
8 
(3-14) 
6 
(1-10) 
6 
(4-12) 
IL-1β 
8 
(4-15) 
5 
(2-11) 
3 
(2-18) 
3 
(2-6) 
 
Table 2. Unstimulated IL-8, IL-6, TNFα and IL-1β release (pg/ml) from patient (n=19) and control (n=19) neutrophils at baseline 
and review. Data presented as median (interquartile range) pg/ml.  For both patient and control cells at baseline and review, levels of IL-8 
were higher than IL-6 (P<0.05), which were higher than TNF and IL-1 (P<0.05).  There were no differences in levels of TNF and IL-1 
released (Dunn’s Test).  * The only significant difference in unstimulated cytokine levels between patient & control cells was for IL-6 at 
review (P=0.033; Bonferroni corrected, 1-tailed Mann-Whitney). 
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Cytokine 
Patient Control 
Comparisons# between patient 
& control cytokine levels at: 
Baseline Review Baseline Review Baseline Review 
IL-8 
18,145 
(7,972-31,936) 
17,467 
(9,043-32,937) 
7,271 
(4,194-13,923) 
8,117 
(4,569-13,380) 
P<0.0001 P<0.0001 
IL-6 
379 
(159-785) 
356 
(139-900) 
200 
(88-474) 
232 
(119-374) 
P=0.004 P=0.01 
TNFα 97* 
(60-224) 
158* 
(60-346) 
69 
(32-127) 
83 
(54-155) 
P=0.016 P=0.008 
IL-1β 
72 
(31-139) 
73 
(26-161) 
34 
(21-92) 
33 
(18-74) 
P=0.002 P=0.002 
 
Table 3. Stimulated IL-8, IL-6, TNFα and IL-1β release (pg/ml) from patient (n=19) and control (n=19) neutrophils at baseline and 
review in the presence of E. coli LPS (5µg/ml), F. nucleatum (MOI 100:1), IgG-opsonised S. aureus (MOI 300:1) and P. gingivalis 
(MOI 100:1). Individual cytokine data presented as median (interquartile range) pg/ml for all stimuli combined (baseline, n=75; review, 
n=76). For both patient and control cells at baseline and review, levels of IL-8 were higher than IL-6 (P<0.001), which were higher than 
TNF and IL-1 (P<0.001).  There were no differences in levels of TNF and IL-1 released (Dunn’s Test).  # Bonferroni corrected, 1-tailed 
Mann-Whitney test.  * P=0.007, Bonferroni corrected, 2-tailed Wilcoxon test. 
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Cytokine Stimulus 
Difference in cytokine 
release between patient 
& control cells 
Change in 
cytokine release 
between baseline 
& review 
Pre-
therapy 
Baseline 
Post-
therapy 
Review 
Patient Control 
IL-8 
None (RPMI) ↔ ↔ ↔ ↔ 
E. coli LPS ↑ (P=0.038) ↑ (P=0.015) ↔ ↔ 
F. nucleatum ↑ (P=0.025) ↔ ↔ ↔ 
ops S. aureus ↑ (P=0.0002) ↑ (P<0.0001) ↔ ↔ 
P. gingivalis 
All stimuli 
↑ (P=0.029) 
↑ (P<0.0001) 
↑ (P=0.009) 
↑ (P<0.0001) 
↔ 
↔ 
↔ 
↔ 
IL-6 
None (RPMI) ↔ ↑ (P=0.033) ↔ (P=0.03) 
E. coli LPS ↔ ↔ ↔ ↔ 
F. nucleatum ↔ ↔ ↔ ↔ 
ops S. aureus ↔ ↑ (P=0.023) ↔ ↔ 
P. gingivalis 
All stimuli 
↔ 
↑ (P=0.004) 
↔ 
↑ (P=0.01) 
↔ 
↔ 
↔ 
↔ 
TNFα 
None (RPMI) ↔ ↔ ↔ ↔ 
E. coli LPS ↔ ↔ ↔ ↔ 
F. nucleatum ↑ (P=0.05) ↔ ↔ ↔ 
ops S. aureus ↑ (P=0.016) ↑ (P=0.009) ↑(P=0.016) ↔ 
P. gingivalis 
All stimuli 
↔ 
↑ (P=0.016) 
↔ 
↑ (P=0.008) 
↑(P=0.035) 
↑(P=0.007) 
↔ 
↔ 
IL-1β 
None (RPMI) ↔ ↔ ↔ ↔ 
E. coli LPS ↔ ↔ ↔ ↔ 
F. nucleatum ↔ ↔ ↔ ↔ 
ops S. aureus ↑ (P=0.046) ↑ (P=0.007) ↔ ↔ 
P. gingivalis 
All stimuli 
↑ (P=0.032) 
↑ (P=0.002) 
↑ (P=0.036) 
↑ (P=0.002) 
↔ 
↔ 
↔ 
↔ 
 
Table 4. Differences in cytokine release between patient and control neutrophils at 
baseline and review in response to individual (n=19; n=18 for opsonised S. aureus at 
baseline) and combined stimuli (n=75 at baseline and n=76 at review) (↑, patient>control; 
↔, patient = control; Bonferroni corrected, 1-tailed Mann-Whitney) and change in 
cytokine release post-therapy (↑, increase;  decrease; ↔, no change at review; 
Bonferroni corrected 2-tailed Wilcoxon).  
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FIGURE LEGENDS 
 
Figure 1. 
Stimulated IL-8 production by neutrophils at baseline, pre-treatment (n=19; n=18 for 
opsonised S. aureus) and review, post-treatment (n=19). Box and whisker plots showing 
median, interquartile range, maximum and minimum. Outliers (values >1.5xIQR) are 
shown as open circles (○) or, if above the y-axis maximum, solid circles (●).  P-values 
calculated using Bonferroni corrected 1-tailed Mann-Whitney test. Stimulated levels of 
IL-8 were significantly greater than those for RPMI control for all stimuli, at baseline and 
review, for both patient and control groups (P<0.0004; Bonferroni corrected, 1-tailed 
Wilcoxon test). 
 
Figure 2. 
Stimulated IL-6 production by neutrophils at baseline, pre-treatment (n=19; n=18 for 
opsonised S. aureus) and review, post-treatment (n=19). Box and whisker plots showing 
median, interquartile range, maximum and minimum. Outliers (values >1.5xIQR) are 
shown as open circles (○) or, if above the y-axis maximum, solid circles (●). P-values 
calculated using Bonferroni corrected, 1-tailed Mann-Whitney test. Stimulated levels of 
IL-6 were significantly greater than those for RPMI control for all stimuli, at baseline and 
review, for both patient and control groups (P<0.0012; Bonferroni corrected, 1-tailed 
Wilcoxon test). 
 
Figure 3. 
Stimulated TNFα production by neutrophils at baseline, pre-treatment (n=19; n=18 for 
opsonised S. aureus) and review, post-treatment (n=19). Box and whisker plots showing 
median, interquartile range, maximum and minimum. Outliers (values >1.5xIQR) are 
shown as open circles (○) or, if above the y-axis maximum, solid circles (●). P-values 
calculated using Bonferroni corrected, 1-tailed Mann-Whitney test. Stimulated levels of 
TNFα were significantly greater than those for RPMI control for all stimuli, at baseline 
and review, for both patient and control groups (P<0.0004; Bonferroni corrected, 1-tailed 
Wilcoxon test). 
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Figure 4. 
Stimulated IL-1β production by neutrophils at baseline, pre-treatment (n=19; n=18 for 
opsonised S. aureus) and review, post-treatment (n=19). Box and whisker plots showing 
median, interquartile range, maximum and minimum. Outliers (values >1.5xIQR) are 
shown as open circles (○) or, if above the y-axis maximum, solid circles (●). P-values 
calculated using Bonferroni corrected, 1-tailed Mann-Whitney test. Stimulated levels of 
IL-1β were significantly greater than those for RPMI control for all stimuli, at baseline 
and review, for both patient and control groups (P<0.0004; Bonferroni corrected, 1-tailed 
Wilcoxon test). 
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Figure 1. Stimulated IL-8 production by neutrophils at baseline, pre-treatment 
(n=19; n=18 for opsonised S. aureus) and review, post-treatment (n=19). Box and 
whisker plots showing median, interquartile range, maximum and minimum. Outliers 
(values >1.5xIQR) are shown as open circles (○) or, if above the y-axis maximum, solid 
circles (●).  P-values calculated using Bonferroni corrected 1-tailed Mann-Whitney test. 
Stimulated levels of IL-8 were significantly greater than those for RPMI control for all 
stimuli, at baseline and review, for both patient and control groups (P<0.0004; Bonferroni 
corrected, 1-tailed Wilcoxon test). 
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Figure 2. Stimulated IL-6 production by neutrophils at baseline, pre-treatment 
(n=19; n=18 for opsonised S. aureus) and review, post-treatment (n=19). Box and 
whisker plots showing median, interquartile range, maximum and minimum. Outliers 
(values >1.5xIQR) are shown as open circles (○) or, if above the y-axis maximum, solid 
circles (●). P-values calculated using Bonferroni corrected, 1-tailed Mann-Whitney test. 
Stimulated levels of IL-6 were significantly greater than those for RPMI control for all 
stimuli, at baseline and review, for both patient and control groups (P<0.0012; Bonferroni 
corrected, 1-tailed Wilcoxon test). 
 
 
 
 
 
0
500
1000
1500
2000
Patient Control Patient Control Patient Control Patient Control Patient Control
RPMI LPS F. nucleatum ops S. aureus P. gingivalis
B
a
s
e
li
n
e
 I
L
-6
 (
p
g
/m
l)
0
500
1000
1500
2000
Patient Control Patient Control Patient Control Patient Control Patient Control
RPMI LPS F. nucleatum ops S. aureus P. gingivalis
R
e
v
ie
w
 I
L
-6
 (
p
g
/m
l)
● ●●●● ●●● ●● ●● ●● ●● 
●●●● ● ● ● 
P=0.033 
P=0.023 
33 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Stimulated TNFα production by neutrophils at baseline, pre-treatment 
(n=19; n=18 for opsonised S. aureus) and review, post-treatment (n=19). Box and 
whisker plots showing median, interquartile range, maximum and minimum. Outliers 
(values >1.5xIQR) are shown as open circles (○) or, if above the y-axis maximum, solid 
circles (●). P-values calculated using Bonferroni corrected, 1-tailed Mann-Whitney test. 
Stimulated levels of TNFα were significantly greater than those for RPMI control for all 
stimuli, at baseline and review, for both patient and control groups (P<0.0004; Bonferroni 
corrected, 1-tailed Wilcoxon test). 
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Figure 4. Stimulated IL-1β production by neutrophils at baseline, pre-treatment 
(n=19; n=18 for opsonised S. aureus) and review, post-treatment (n=19). Box and 
whisker plots showing median, interquartile range, maximum and minimum. Outliers 
(values >1.5xIQR) are shown as open circles (○) or, if above the y-axis maximum, solid 
circles (●). P-values calculated using Bonferroni corrected, 1-tailed Mann-Whitney test. 
Stimulated levels of IL-1β were significantly greater than those for RPMI control for all 
stimuli, at baseline and review, for both patient and control groups (P<0.0004; Bonferroni 
corrected, 1-tailed Wilcoxon test). 
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